In this webinar, industry experts from Precision for Medicine will provide insights on developing gene therapy immunogenicity assays focused on regulatory compliance, minimizing rework, and selecting the right assay approach.
Learn best practices for immunogenicity assay validation, cost-effective strategies, and future-proof assay designs. Compare neutralizing antibody (NAb) and total antibody (TAb) assays and their effects on timelines, costs, and clinical outcomes. Whether you're in early development or optimizing later-phase trials, this session ensures your assays meet global standards, are robust, compliant, and scalable.
Topics covered
Watch now.
Offered Free by: Precision for Medicine
See All Resources from: Precision for Medicine